Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:00 PM ET 8-K
Leadership Change Warner Music Group Corp. WMG

Warner Music Group Leadership Change

Carianne Marshall will step down as Co-Chair and Chief Operating Officer of Warner Chappell Music, effective September 30, 2026, remaining as an advisor through January 8, 2027. Under a separation agreement, she will receive 18 months of salary, a $116,000 lump sum payment, and a one-time equity award valued at $1.5 million. The departure appears to be a planned transition as she will provide advisory services during the handover period.

Counterparty
Carianne Marshall
4:59 PM ET 8-K
Deal Termination Dalrada Technology Group, Inc. DHTI

Dalrada Technology Group Deal Termination with IBS Equity Fund III, LLC and IBS Private Credit Fund IV, LLC

Dalrada Technology Group's subsidiary, Genefic, Inc., has terminated its financing relationship with IBS Equity Fund III and IBS Private Credit Fund IV, which included a $20 million standby letter of credit facility and a $5 million credit facility. Although no funding was ever received under these agreements, IBS has asserted events of default and is demanding early termination fees and the acceleration of obligations, which the company disputes.

Counterparty
IBS Equity Fund III, LLC and IBS Private Credit Fund IV, LLC
4:55 PM ET 8-K
M&A Deal Talos Energy Inc. TALO

Talos Energy Signs $420M M&A Deal with Shell Offshore Inc.

Talos Energy completed the acquisition of a 50% interest in the Coulomb field and a 25% interest in the Na Kika platform and associated fields from Shell Offshore Inc. for a final net cash closing price of $420 million. The deal enhances Talos's scale in the Gulf of Mexico and includes operatorship of the Coulomb field.

Value
$420M
Counterparty
Shell Offshore Inc.
Earnings call
Nov 4, 2026, 10:00 AM ET
4:52 PM ET 8-K
Loan & Debt LandBridge Co LLC LB

LandBridge Co $125M Debt Financing

LandBridge subsidiary DBR Land Holdings LLC priced an upsized private placement of $125 million in 6.250% Senior Notes due 2030 at 99.375% of par. The offering was increased from an initial $100 million and the proceeds will be used to repay outstanding borrowings under the company's revolving credit facility.

Value
$125M
Term
through 2030
4:50 PM ET 8-K
Capital Raise Blackstone Multi-Strategy Hedge Fund L.P.

Blackstone Multi-Strategy Hedge Fund Capital Raise of $67M

Blackstone Multi-Strategy Hedge Fund L.P. sold unregistered limited partnership units for aggregate consideration of approximately $67.0 million on September 1, 2026. The sale was part of the Fund's continuous private offering to accredited investors and qualified purchasers, with the majority of proceeds ($63.3 million) coming from Class I-F units.

Value
$67M
4:47 PM ET 8-K
Loan & Debt Verizon Master Trust

Verizon Master Trust $1B Debt Financing with U.S. Bank Trust Company, National Association

Verizon Master Trust completed the issuance of $1.0 billion in asset-backed notes across four classes (A-1a, A-1b, B, and C) on September 22, 2026. The transaction involved entering into a new indenture and account control agreement with U.S. Bank Trust Company as the indenture trustee.

Value
$1B
Counterparty
U.S. Bank Trust Company, National Association
4:45 PM ET 8-K
Investor Meeting Labcorp Holdings Inc. LH

Labcorp Holdings Investor Meeting

Labcorp is reaffirming its 2026-2029 long-term financial outlook following the release of preliminary Medicare payment rates by CMS. The company expressed concern that the proposed rates would impose steep annual cuts and is continuing to support the bipartisan RESULTS Act to ensure a sustainable laboratory system.

Counterparty
Centers for Medicare & Medicaid Services (CMS)
Term
2026-2029
4:41 PM ET 8-K
Loan & Debt Halozyme Therapeutics, Inc. HALO

Halozyme Therapeutics $1.5B Debt Financing with The Bank of New York Mellon Trust Company, N.A.

Halozyme Therapeutics completed the sale of $1.5 billion in 1.50% Convertible Senior Notes due 2033, which included a $200 million overallotment option exercised by initial purchasers. The company used the proceeds to fund capped call transactions and to repurchase approximately $652.5 million of its existing 0.25% notes due 2027 and 1.00% notes due 2028.

Value
$1.5B
Counterparty
The Bank of New York Mellon Trust Company, N.A.
Term
through 2033
4:35 PM ET 8-K
M&A Deal Rocket One Inc. RKTO

Rocket One M&A Deal with Tracer Drone Technologies, LLC

Rocket One Inc. has entered into a definitive agreement to acquire 100% of Tracer Drone Technologies, LLC, a provider of drone hardware, software, and managed services. The acquisition aims to accelerate Rocket One's expansion into AI-enabled autonomous and counter-UAS technologies for public safety and defense markets. Tracer will operate as a wholly owned subsidiary upon the closing of the transaction.

Counterparty
Tracer Drone Technologies, LLC
4:33 PM ET 8-K
Stock Buyback Apollo Debt Solutions BDC ADS

Apollo Debt Solutions BDC Announces $700M Stock Buyback

Apollo Debt Solutions BDC (ADS) provided an update on its Q3 2026 share repurchase program, stating it will honor repurchase requests for 5% of shares outstanding, totaling approximately $700 million. The Fund received total repurchase requests for 14.7% of shares outstanding but is limiting outflows to its designated 5% quarterly liquidity cap. ADS reported $4.8 billion in available liquidity and a year-to-date net total return of 3.7% for Class I shares.

Value
$700M
Term
Q3 2026
4:33 PM ET 8-K
Licensing Deal Interparfums Inc IPAR

Interparfums Licensing Deal with Puma

Interparfums has entered into an exclusive, worldwide license agreement with PUMA for the creation, development, production, and distribution of fragrances under the PUMA brand. The agreement runs through December 31, 2037, with the company planning to launch a new signature lifestyle fragrance in 2027.

Counterparty
PUMA
Term
through Dec 2037
4:33 PM ET 8-K
Divestiture Ares Commercial Real Estate Corp ACRE

Ares Commercial Real Estate Divestiture to unaffiliated buyer for $64M

Ares Commercial Real Estate Corporation completed the sale of a multi-building office property in North Carolina for $64 million in cash. The company had previously acquired the property through a deed in lieu of foreclosure in September 2024 and had classified it as held for sale since early 2026.

Value
$64M
Counterparty
unaffiliated buyer
4:32 PM ET 8-K
Dividend Apollo Debt Solutions BDC ADS

Apollo Debt Solutions BDC Dividend

Apollo Debt Solutions BDC declared monthly distributions for September 2026 of $0.1800 per share for Class I, S, and D common shares. The company also reported a net asset value (NAV) per share of $23.84 as of August 31, 2026, and disclosed the sale of approximately $8.5 million in Class I common shares through a private offering.

4:31 PM ET 8-K
Loan & Debt Energy Vault Holdings, Inc. NRGV

Energy Vault Holdings $25M Debt Financing with S2G Builders Special Opportunities Fund I, LP

Energy Vault's subsidiary, Development Vault, LLC, entered into an amended and restated financing agreement for a $25 million senior secured delayed draw term loan facility. The facility, which currently has $18 million outstanding, carries a 10.0% cash interest rate plus a 7.0% PIK interest rate and matures in April 2030. Proceeds will be used to fund the acquisition and development of battery energy storage projects, including equipment deposits and interconnection costs.

Value
$25M
Counterparty
S2G Builders Special Opportunities Fund I, LP
Term
through April 16, 2030
4:31 PM ET 8-K
Capital Raise Alaunos Therapeutics, Inc. TCRT

Alaunos Therapeutics Capital Raise of $1.12M

Alaunos Therapeutics entered into a securities purchase agreement for a registered direct offering of 380,469 shares of common stock and 386,654 pre-funded warrants. The offering was priced at $1.46 per share, generating aggregate gross proceeds of approximately $1.12 million. The company intends to use the net proceeds for general corporate purposes and working capital.

Value
$1.12M
Counterparty
institutional investors
4:31 PM ET 8-K
Leadership Change Caring Brands, Inc. CABR

Caring Brands Leadership Change

Caring Brands, Inc. appointed Brian R. Meadows as Chief Financial Officer and principal financial officer, effective September 18, 2026, succeeding Brian John who resigned as Interim CFO and Chairman. Dr. Glynn Wilson, the current CEO, was appointed as the new Chairman of the Board. Mr. Meadows will provide services through a consulting agreement with Myall Luna Ventures Inc., which was amended to increase the monthly fee from $10,000 to $15,000.

4:31 PM ET 8-K
Leadership Change Quantum X Labs Inc. QXL

Quantum X Labs Leadership Change

Mr. Amihay Hadad has stepped down as Co-Chief Executive Officer of Quantum X Labs Inc., effective September 22, 2026. Consequently, Mr. Yakov Baranes, who previously served as Co-CEO, has been appointed as the company's sole Chief Executive Officer.

4:31 PM ET 8-K
Other 8-K Filing Black Hawk Acquisition Corp BKHA

Black Hawk Acquisition Other 8-K Filing

Black Hawk Acquisition Corporation has deposited $150,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline by one month, from September 22, 2026, to October 22, 2026.

Term
1 month
4:31 PM ET 8-K
Dividend First Eagle Private Credit Fund

First Eagle Private Credit Fund Dividend

First Eagle Private Credit Fund declared regular September 2026 distributions of $0.210 per share for both Class I and Class D common shares. The distributions are payable on October 29, 2026, to shareholders of record as of September 30, 2026. The filing also updated the Fund's NAV to $23.74 per share as of August 31, 2026.

4:28 PM ET 8-K
Dividend Ares Strategic Income Fund

Ares Strategic Income Fund Dividend

Ares Strategic Income Fund declared monthly distributions for September, October, November, and December 2026 for its Class I, S, and D shares. The gross distribution for each month is set at $0.21430 per share, with the September distribution payable on October 23, 2026, to shareholders of record as of September 30, 2026.

4:25 PM ET 8-K
Loan & Debt Group 1 Automotive Inc GPI

Group 1 Automotive $1.25B Debt Financing with Computershare Trust Company, N.A.

Group 1 Automotive completed a private offering of $1.25 billion in senior notes, consisting of $625 million of 6.250% notes due 2032 and $625 million of 6.625% notes due 2035. The company intends to use the net proceeds of approximately $1,236 million to fund its previously announced acquisition of dealership assets from Hennessy Automobile Companies, Inc. and to repay existing credit facility debt.

Value
$1.25B
Counterparty
Computershare Trust Company, N.A.
Term
through 2035
4:23 PM ET 8-K
Capital Raise Medallion Financial Corp MFIN

Medallion Financial Capital Raise

Medallion Bank, a subsidiary of Medallion Financial Corp., has launched a public offering of additional shares of its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series G. The bank intends to use the proceeds for general corporate purposes, which may include redeeming its outstanding Series E Preferred Stock.

4:23 PM ET 8-K
Clinical Trial Data Vistagen Therapeutics, Inc. VTGN

Vistagen Therapeutics Clinical Trial Data

Vistagen announced preliminary positive data from the open-label extension portion of its PALISADE-4 Phase 3 study of fasedienol for social anxiety disorder. The data showed the nasal spray was well-tolerated over 12 months of as-needed use and demonstrated clinically relevant improvements in social anxiety symptoms on both clinician-administered and patient-reported scales. The company plans to meet with the FDA this quarter to discuss the regulatory path forward for a potential New Drug Application.

Term
12 months
4:22 PM ET 8-K
Other 8-K Filing Bank of New York Mellon Corp BNY

Bank of New York Mellon Other 8-K Filing

The Bank of New York Mellon Corporation filed a Certificate of Elimination to its Restated Certificate of Incorporation to remove all designations related to its Series F Noncumulative Perpetual Preferred Stock. This administrative action follows the full redemption of all outstanding Series F shares on September 20, 2026.

4:22 PM ET 8-K
Financial Results Worthington Enterprises, Inc. WOR

Worthington Enterprises Financial Results

Worthington Enterprises reported fiscal 2027 first quarter results with net sales increasing 13% to $343.9 million and net earnings rising 22% to $42.6 million. The company achieved 7% organic growth and nearly doubled its free cash flow to $54.0 million while also declaring a $0.20 per share quarterly dividend.

Term
Q1 2027
Earnings call
Sep 23, 2026, 8:30 AM ET

“We started fiscal 2027 with solid performance as our teams continued to execute well and deliver for our customers. We generated 7% organic growth, grew adjusted EBITDA by 10% and nearly doubled free cash flow. These results reflect the progress we are making as we continue to optimize and grow Worthington Enterprises.”

Joe Hayek, President and CEO
4:22 PM ET 8-K
Other 8-K Filing LeonaBio, Inc. LONA

LeonaBio Other 8-K Filing

LeonaBio announced that Series A Common Warrants issued in a December 2025 private placement have become exercisable as of September 18, 2026. If the warrants are exercised in full for cash at the $6.35 exercise price, the company would receive approximately $146.2 million in additional capital. The warrants remain exercisable until October 19, 2026.

Term
through Oct 19, 2026
4:19 PM ET 8-K
Other 8-K Filing Aldel Financial II Inc. ALDFF

Aldel Financial II Other 8-K Filing

Aldel Financial II Inc. announced that its sponsor and other holders will convert 6,160,713 Class B ordinary shares into Class A ordinary shares on a one-for-one basis effective October 5, 2026. Following the conversion, the company will have 29,868,213 Class A shares and only one Class B share outstanding. The holders waived any rights to funds in the company's trust account regarding these converted shares.

Counterparty
Aldel Investors II LLC
4:18 PM ET 8-K
Nasdaq/NYSE Compliance Notice Reborn Coffee, Inc. REBN

Reborn Coffee Nasdaq/NYSE Compliance Notice

Reborn Coffee received a deficiency notice from Nasdaq on September 16, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million, reporting only $735,642 in its latest quarterly filing. The company has until November 2, 2026, to submit a plan to regain compliance, which could lead to a 180-day extension if accepted. Separately, Nasdaq confirmed the company regained compliance regarding its periodic filing requirements after the late 10-Q was submitted.

Counterparty
Nasdaq
Term
45 days
4:17 PM ET 8-K
Loan & Debt CoreWeave, Inc. CRWV

CoreWeave $4.2B Debt Financing with U.S. Bank Trust Company, National Association

CoreWeave completed an upsized private offering of $4.2 billion in 2.875% Convertible Senior Notes due 2033, which included the full exercise of a $500 million overallotment option. The notes are senior unsecured obligations guaranteed by certain subsidiaries and are convertible into cash, Class A common stock, or a combination thereof at an initial conversion price of approximately $97.85 per share.

Value
$4.2B
Counterparty
U.S. Bank Trust Company, National Association
Term
through April 2033

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.